University College London
Institute of Immunity and Transplantation
The Institute of Immunity and Transplantation is a joint initiative between UCL and the Royal Free London NHS Foundation Trust. It forms a key part of the university’s strategy to work with partners on quickly translating research discoveries into patient therapies.
The institute will bring together multi-disciplinary teams of scientists, academic clinicians, clinical trial specialists and nurses. These teams will aim to:
- develop therapies that enhance immunity for the treatment of cancer and chronic infection
- identify ways to treat autoimmune conditions and prevent immune attack of conventional and bioengineered transplants.
To consolidate the strength of its research, the institute will partner with another biomedical research centre - the Francis Crick Institute. Working with other university partners will also provide access to a patient population of six million.
State-of-the-art research labs, equipment and clinical-trial facilities will allow researchers to rapidly adapt their research methods to produce therapeutics for trial with patients.
The institute will work with industry and the technology and innovation centre, Cell Therapy Catapult. This will help to increase the scale of the institute’s work and develop new forms of tissue, cell and gene therapy for the benefit of patients.
Phase I of the Institute, comprising 1800m2 of refurbished space, opened in June 2013. A new institute building will be completed in 2017, and will provide space for 20-25 research groups, each with 8-10 researchers.